
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014. It forms part of
("Insig AI", the "Company" or the "Group")
Equity fundraise
Insig AI is also pleased to report that unaudited revenues for the six months to
Insig AI is also pleased to announce that CMC has been appointed as the Company's joint corporate broker.
Admission and Total Voting Rights
Application will be made to the London Stock Exchange for admission of the Placing Shares to trading on AIM ("Admission"). Admission is expected to become effective, and dealings in the Subscription Shares are anticipated to commence on or around 13 October 2025.
Following Admission, the issued share capital and total voting rights of the Company will be 123,349,309. Shareholders may use this figure as the denominator to determine if they are required to notify their interest in, or a change to their interest in, the Company under the
For further information, please visit www.insig-ai.com or contact:
Zeus (Nominated Adviser & Joint Broker) David Foreman / James Hornigold |
+44 (0) 203 829 5000 |
CMC Markets (Joint Broker)
Douglas Crippen + 44 (0) 203 003 8632
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the